glutathione sepharose 4b beads - an overview wash and elution buffers Pierce™ Glutathione Magnetic Agarose Beads
Description
Therefore, reduce the dose or increase the dosing interval
Efficacy: Primary Endpoint: Change in average daily normalized On time without troublesome dyskinesia at 12 weeks
The recommended dose of ALIMTA for treatment of recurrent non-squamous NSCLC in patients with a creatinine clearance (calculated by Cockcroft-Gault equation) of 45 mL/min or greater is 500 mg/m2 as an intravenous infusion over 10 minutes on Day 1 of each 21-day cycle until disease progression or unacceptable toxicity
Finalized records display only the methods, fields, and results present in the applicable source file.
